Steminent Biotherapeutics Inc.
7729.TWO
Taipei Exchange73.90
TWD
-0.10
- -
Total Valuation
Steminent Biotherapeutics Inc. carries a market capitalization of 5.40B, placing it among publicly traded companies globally.
| Market Cap | 5.40B |
| Enterprise Value | N/A |
Stock Price Statistics
Steminent Biotherapeutics Inc.'s stock has gained approximately 256.14458% over the past 52 weeks. The 50-day moving average sits at 75.74, while the 200-day moving average is 65.64.
| Beta (5Y) | N/A |
| 52-Week Price Change | 256.14458% |
| 50-Day Moving Average | 75.74 |
| 200-Day Moving Average | 65.64 |
| Average Volume (20 Days) | N/A |
Stock Splits
Steminent Biotherapeutics Inc.'s most recent stock split took place on April 29, 2026 with a 200:203 split ratio.
| Last Split Date | 4/29/2026 |
| Split Ratio | 200:203 |